Oystershell has come to an agreement with Bayer HealthCare LLC to acquire RID®, one of the leading brands in lice treatment in the US.
RID® is known for its strong consumer brand awareness, high levels of professional endorsement and its well-respected brand logo and attributes. In 2019, RID® achieved 25 million USD in retail sales and is the #2 brand in the US lice treatment market.